Close

UroGen Pharma (URGN) Files Patent Infringement Action Against Teva Pharmaceuticals (TEVA) Apr 3, 2024 08:03AM
Teva’s Digital Health Collaboration with Rimidi Expands to Include Respiratory Monitoring Program Integration with a Large U.S. Health System Mar 27, 2023 08:00AM
Vanda Pharmaceuticals (VNDA) Responds to Ruling in HETLIOZ ANDA Litigation, Intends to Appeal Dec 13, 2022 03:16PM
Teva Announces Unique Collaboration with Rimidi to Expand the Reach of its Respiratory Digital Health Platform Nov 14, 2022 08:01AM
Teva Launches Honestly HD Website to Provide People Living With Huntington’s Disease (HD) Information, Inspiration and Resources on HD Chorea Sep 26, 2022 08:00AM
View Older Stories

Jan 19, 2022 08:00AM PepGen Appoints Laurie Keating as Chair of Board of Directors
Nov 25, 2021 12:00PM Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.
Oct 7, 2021 02:20PM Alvotech Beats Back AbbVie’s Trade Secrets Lawsuit
Sep 20, 2021 10:23AM Alvotech Provides Update on FDA Action Regarding AVT02, Proposed High-Concentration Biosimilar to Humira® (adalimumab)
Sep 9, 2021 02:02PM Alvotech Announces Positive Top-Line Results for Switching Study Between Proposed Biosimilar AVT02 and Humira (TEVA)
Sep 9, 2021 02:00PM Alvotech Announces Positive Top-Line Results for Switching Study Between Proposed Biosimilar AVT02 and Humira®
Aug 5, 2020 07:10AM Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market
Jan 22, 2020 09:21AM Ironwood Pharma (IRWD), Allergan (AGN) Settle LINZESS (linaclotide) Patent Litigation with Teva (TEVA)
Oct 24, 2019 06:10AM Several states wary of $48 billion opioid settlement proposal
Dec 5, 2018 05:51AM Citi Appointed as Successor Depositary Bank for Teva’s ADR Programme
Oct 17, 2018 09:01AM Express Scripts (ESRX) Announces New Value-Based Program for Migraine
Sep 17, 2018 09:28AM Pre-Open Movers 09/17: (SNMX) (NBEV) (SIR) Higher; (RSLS) (PBYI) (TWTR) Lower (more...)
Aug 16, 2018 07:01AM Regeneron (REGN), Teva (TEVA) Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from OA of Knee or Hip
Aug 16, 2018 07:00AM Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Aug 16, 2018 07:00AM Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Feb 8, 2018 09:26AM Pre-Open Movers 02/08: (TWTR) (INFN) (GRUB) Higher; (IRBT) (GEMP) (IPHI) Lower (more...)
Jan 22, 2018 09:29AM Pre-Open Movers 01/22: (BIVV) (JUNO) (ARRY) Higher; (SANM) (TEVA) (TWTR) Lower (more...)
Sep 18, 2017 11:30AM New Initiative Creates Scalable Solutions to Improve Care of Patients with Multiple Chronic Conditions
May 15, 2017 08:08AM Teva (TEVA), Otsuka Sign Licensing Agreement for Japan on Migraine Drug Candidate Fremanezumab
May 15, 2017 08:00AM Otsuka and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine Drug Candidate Fremanezumab (TEV-48125)
Oct 17, 2016 07:05AM Teva Pharma (TEVA), Regeneron (REGN) Announce FDA Clinical Hold Placed on Fasinumab Phase 2b
Oct 17, 2016 07:00AM Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
Oct 17, 2016 07:00AM Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
Sep 20, 2016 07:03AM Regeneron (REGN), Teva Pharma (TEVA) Enter Partnership for Fasinumab Development, Commercialization
Sep 20, 2016 07:00AM Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
Sep 20, 2016 07:00AM Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
Jul 27, 2016 02:30PM FTC: Teva (TEVA) Agrees to Divest 79 Pharma Products to Settle Actavis (AGN) Generics Merger Issues
Oct 15, 2015 08:15AM Cocrystal Pharma Announces Late Breaking Abstract at AASLD Meeting (OPK) (TEVA)
Sep 28, 2015 08:00AM BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Receives FDA Fast-Track Designation for OpRegen® for the Treatment of the Dry Form of Age-Related Macular Degeneration
Jul 31, 2015 03:54PM Top 10 News for 7/27 - 7/31: Teva Makes it Official with Allergan; China Stock Slide Continues; Revised Q2 GDP Misses Mark
May 13, 2015 08:00AM BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.6 Million Grant From Israel’s Office of the Chief Scientist
Apr 27, 2015 06:30AM OncoGenex Regains Rights to Custirsen from Teva
Apr 21, 2015 12:19PM Streetinsider.com's Hot Lunchtime Reads 4/21: (GS) (TEVA) (INO) (TWTR)
Feb 4, 2015 03:50PM Trading Radar for 2/4: Twitter (TWTR), GoPro (GPRO), LinkedIn (LNKD), Kors (KORS), Philip Morris (PM) Report
Apr 16, 2014 10:38AM Notable Analyst Rating Changes 04/16: (SFUN) (TWTR) (YELP) Upgraded; (INTC) (UNH) (GDP) Downgraded
Jan 8, 2014 09:32AM Pre-Open Stock Movers 1/8: (PATH) (FRX) (MU) Higher; (TCS) (JCP) (TWTR) Lower (more...)
Dec 27, 2013 01:11PM Unusual 11 Mid-Day Movers 12/27: (WPCS) (FREE) (ANIP) Higher; (IFON) (CLWT) (APRI) Lower
Dec 27, 2013 09:29AM Pre-Open Stock Movers 12/27: (WPCS) (ANIP) (FE) Higher; (TWTR) (PTRY) (BBRY) Lower (more...)
Nov 4, 2013 10:44AM Notable Analyst Rating Changes 11/04: (X) (GTI) (KSS) Upgraded; (BPI) (GPS) (AFL) Downgraded
Oct 16, 2013 09:31AM Pre-Open Stock Movers 10/16: (RCPT) (AAP) (MAT) Higher; (SWK) (MCP) (JOEZ) Lower (more...)
Sep 20, 2013 12:21PM Alexza's EU Partner (Grupo Ferrer) Signs New ADASUVE Deal With Medivir
Jun 12, 2013 05:22PM Market Wrap: Dow Closes Below 15K; Gigamon Goes Public; 10-Year Pfizer Fight Ends
View Older Stories